The effect of interval time of transcatheter arterial chemoembolization with drug-eluting beads on the efficacy and safety of unresectable hepatocellular carcinoma: a case-control study
DEB-TACE performed at intervals longer than 4 weeks has a better prognosis for HCC than DEB-TACE performed within 4 weeks without increasing adverse reactions.
Authors
- Haotian Xue
- Kaizhong Zheng (ORCID: https://orcid.org/0000-0002-9723-3227)
- Chang Zhao
- Guang Deng (ORCID: https://orcid.org/0000-0003-1803-4578)
- Huaqing Zhang (ORCID: https://orcid.org/0000-0002-4218-7542)
Institutions
- Guangxi Medical University (CN)
- Tumor Hospital of Guangxi Medical University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-10-20
- DOI
- https://doi.org/10.3389/fonc.2025.1679167
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00